Clinical Trial Obstructive Sleep Apnea

OR

Researchers from the Sleep and Attention Disorders Institute are conducting a research study in a population of people with obstructive sleep apnea (OSA)

This study looks at how two investigational drugs, called AD109 and AD504, work as study treatments for obstructive sleep apnea.

You may be eligible to participate in this research study if you:

· Are a male between the ages of 18 and 65;

· A female between the ages of 18 and 75;

· Have been diagnosed with obstructive sleep apnea (OSA)

There will be 7 visits to the study site, 4 of which are overnight stays to measure your sleep. The study takes up to 44 days to complete

Compensation (up to $1500) will be provided for time and travel.

If you are interested in volunteering or would like to obtain additional information about this research study, please call us at

586-254-0707

View more Sleep and Attention Disorders Institute Patient Reviews on the following websites:
What Our Patients Say

I enjoy comeing in to see the Dr. because of all the great people he has working for him. You all are so good that I fell like I am at home when I come in.

Joesph O'Bryan

Dr. Sangal and his office staff are so pleasant and made me feel so comfortable. I was always able to schedule an appointment quickly and my treatment showed immediate improvements to my sleep.

Tired mom of three

I think Dr. Sangal and his staff are wonderful. Everyone is polite and caring. Dr. Sangal has extended my life by diagnosing my sleep apnea and putting me on a treatment plan. I was headed for a stroke and didn’t know it. Thank you Dr. Sangal for all your good care!

La-Von

I have been extremely impressed with Dr. Sangal and all of his staff. Everyone has been so helpful and wonderfull explaining all the testing to us. We felt right at home when my daugther did her sleep apnea test, she was very comfortable. I recommend Dr. Sangal, Im very happy with everything.

Angie

This has been one of the most beneficial medical treatments I have evern received. Good treatments might deliver most of what is expected. But Dr. Sangal & his team delivered 100% of what I needed. I feel great!

A M

What an amazing sleep facility. I was very impressed with the hotel-type accomodations in my room. Because I also deal with asthma, my breathing was difficulty for a while before sleeping. Both the Sleep Techs were very attentive and made certain I was comfortable. Outstanding experience!

Nan

It is great to be able to rest, and to be able to think again. My sleep is clear and restful and I have more energy and I am loving it! Thank you Dr. Sangal.

Nathan Johnson

I had the sleep study on Wed nite, 11-27. The 2 girls who helped were so kind & cheerful & good natured. Couldn’t have been nicer.

MA

I have used CPAP every night for more than 15 years. Dr. Sangal has worked with me over time and I believe CPAP treatment has made my life, in general, easier; reducing fatigue which had built up over the years in my profession. I am today more relaxed and better able to handle the problems and anxieties of life, and am better able to enjoy my family and relate better to friends and associates. I am 77 years old.

Cookie

Dr. Sangal not only has helped my son’s ADHD, but the staff is helpful & courteous, and Dr. Sangal always runs on time & we never wait very long.

Tara Yagonczak

News & Blog

What is the Best Pillow? Patients often ask us, “What is the best pillow?” Patients also ask whether there is a pillow to use with CPAP, or a pillow that treats snoring and sleep apnea. According to Consumer Reports, the best pillow is Coop Home Goods Premium Adjustable Loft, followed closely by Sleep Number ComfortFit…

Amphetamines should not be stimulants of first choice

September 17, 2021

Amphetamines should not be stimulants of first choice Amphetamines in DEA Schedule 2 (AdderallR, DexedrineR, VyvanseR) are the most commonly prescribed stimulants in the USA. These amphetamines should not be the stimulants of first choice. However, amphetamine use increased 2.5 fold from 2006 to 2016. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261411/) Stimulant medicines (amphetamines, methylphenidate, modafinil, armodafinil, solriamfetol) are generally…

Obstructive Sleep Apnea Almost Doubles the Risk of Sudden Death

August 4, 2021

Obstructive Sleep Apnea Almost Doubles the Risk of Sudden Death A large analysis of 22 studies with 42099 subjects showed that obstructive sleep apnea (OSA) almost doubles the risk of sudden death. The risk of sudden death of any cause was increased by 74%, and the risk of cardiovascular deaths by 95%. The authors looked…